Clearstead Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,677
Closed -$571K 2292
2025
Q4
$571K Buy
2,677
+1,860
+228% +$384K 0.01% 619
2025
Q3
$162K Sell
817
-32
-4% -$5.97K ﹤0.01% 924
2025
Q2
$147K Buy
849
+791
+1,364% +$129K ﹤0.01% 962
2025
Q1
$9.04K Hold
58
﹤0.01% 1626
2024
Q4
$7.99K Sell
58
-1,085
-95% -$143K ﹤0.01% 1633
2024
Q3
$171K Sell
1,143
-21
-2% -$2.84K ﹤0.01% 904
2024
Q2
$159K Buy
1,164
+109
+10% +$14.8K ﹤0.01% 887
2024
Q1
$139K Buy
1,055
+140
+15% +$20K 0.01% 530
2023
Q4
$115K Sell
915
-775
-46% -$77.3K 0.01% 559
2023
Q3
$158K Buy
1,690
+529
+46% +$49.5K ﹤0.01% 624
2023
Q2
$104K Buy
1,161
+541
+87% +$47.1K 0.01% 572
2023
Q1
$66.5K Buy
+620
New +$70.9K ﹤0.01% 596

Other funds holding ASND